SCHEMBL8506348

SCHEMBL8506348

O=C(O)c1cc2c3cc(Br)c(Br)cc3n(Cc3ccccc3)c2s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 4/20 0.43
CCR2 P41597 1/20 0.40
KMT2A Q03164 3/20 0.40
MITF O75030 1/20 0.40
MAPT P10636 1/20 0.40
OXTR P30559 1/20 0.40
AVPR1A P37288 1/20 0.40
BLM P54132 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RHEB Q15382 1/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PLA2G2A P14555 1/20 0.38
FABP4 P15090 1/20 0.38
PPARG P37231 1/20 0.38
GPR35 Q9HC97 1/20 0.38
LMNA P02545 1/20 0.38
NOTUM Q6P988 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8507003 0.86 PLA2G2A (0.48) SRCKMT2AMAPTALDH1A1PLA2G2A
SCHEMBL8503749 0.84 CYP19A1 (0.54) CCR2KMT2AMAPTNPSR1KDM4E
SCHEMBL8506884 0.82 SRC (0.41) SRCCCR2KMT2AMITFMAPT
SCHEMBL8504351 0.77 PLA2G2A (0.52) KMT2AMAPTNPSR1KDM4EALDH1A1
SCHEMBL8505246 0.75 CYP19A1 (0.53) CCR2KMT2AMAPTNPSR1KDM4E
SCHEMBL8504364 0.74 CYP19A1 (0.51) CCR2KMT2AMAPTKDM4EALDH1A1
SCHEMBL8506149 0.74 KDM4E (0.54) KMT2AMAPTNPSR1KDM4EALDH1A1
SCHEMBL2996558 0.73 ALDH1A1 (0.45) CCR2KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL6254110 0.70 TRPA1 (0.48) KMT2AKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL8506152 0.69 CYP19A1 (0.44) KMT2AMAPTKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750621-B1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1999-07-21 EP claimed
EP-0750621-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-01-02 EP claimed
WO-1995025110-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-09-21 WO claimed
EP-0750621-B1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1999-07-21 EP disclosed
US-5783575-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1998-07-21 US disclosed
EP-0750621-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-01-02 EP disclosed
US-5536721-A Thieno[2,3-b-indole derivatives and their use for treating central nervous system diseases related to the metabotropic glutamate receptor system NOVO NORDISK A/S (DK) 1996-07-16 US disclosed
WO-1995025110-A1 HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-09-21 WO disclosed